, Volume 10, Issue 2, pp 359–368 | Cite as

α-lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2 −.-generation

  • U. WenzelEmail author
  • A. Nickel
  • H. Daniel


The antioxidant α-lipoic acid (ALA) has been shown to affect a variety of biological processes associated with oxidative stress including cancer. We determined in HT-29 human colon cancer cells whether ALA is able to affect apoptosis, as an important parameter disregulated in tumour development. Exposure of cells to ALA or its reduced form dihydrolipoic acid (DHLA) for 24 h dose dependently increased caspase-3-like activity and was associated with DNA-fragmentation. DHLA but not ALA was able to scavenge cytosolic O2 −. in HT-29 cells whereas both compounds increased O2 − .-generation inside mitochondria. Increased mitochondrial O2 − .-production was preceded by an increased influx of lactate or pyruvate into mitochondria and resulted in the down-regulation of the anti-apoptotic protein bcl-XL. Mitochondrial O2 −.-generation and apoptosis induced by ALA and DHLA could be prevented by the O2 − .-scavenger benzoquinone. Moreover, when the lactate/pyruvate transporter was inhibited by 5-nitro-2-(3-phenylpropylamino) benzoate, ALA- and DHLA-induced mitochondrial ROS-production and apoptosis were blocked. In contrast to HT-29 cells, no apoptosis was observed in non-transformed human colonocytes in response to ALA or DHLA addition. In conclusion, our study provides evidence that ALA and DHLA can effectively induce apoptosis in human colon cancer cells by a prooxidant mechanism that is initiated by an increased uptake of oxidizable substrates into mitochondria.


HT-29 human colon cancer cells mitochondrial apoptosis pathway monocarboxylate transporter superoxide anion generation 





Alpha-lipoic acid




Confocal laser scanning microscopy




glyceraldehyd-3-phosphate dehydrogenase


modified Eagle medium





proxyl fluorescamine

5-(2-carboxyphenyl)-5-hydroxy-1-((2,2,5,5-tetramethyl-1-oxy- pyrrolidin-3-yl)methyl)-3-phenyl-2-pyrrolin-4-one, potassium salt


reactice oxygen species


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gackowski D, Banaszkiewicz Z, Rozalski R, Jawien A, Olinski R. Persistent oxidative stress in colorectal carcinoma patients. Int. J. Cancer 2002; 101: 395–397.PubMedGoogle Scholar
  2. 2.
    Glaab WE, Hill RB, Skopek TR. Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells. Carcinogenesis 2001; 22: 1709–1713.PubMedGoogle Scholar
  3. 3.
    Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001; 389: 84–93.PubMedGoogle Scholar
  4. 4.
    Paganelli GM, Biasco G, Brandi G, et al. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 1992; 84: 47–51.PubMedGoogle Scholar
  5. 5.
    Moghadasian MH, Freeman HJ, Godin DV. Endogenous antioxidant status in neoplastic and adjacent tissues in 1,2-dimethylhydrazine-induced colon cancer in rats: Effects of olsalazine. Carcinogenesis 1996; 17: 983–987.PubMedGoogle Scholar
  6. 6.
    Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227–250.CrossRefPubMedGoogle Scholar
  7. 7.
    Mantovani G, Maccio A, Madeddu C, et al. The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: Correlation with disease progression. Free Radic Res 2003; 37: 213–223.PubMedGoogle Scholar
  8. 8.
    Mantovani G, Maccio A, Madeddu C, et al. Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: Impact of an antioxidant treatment. J Environ Pathol Toxicol Oncol 2003; 22: 17–28.PubMedGoogle Scholar
  9. 9.
    Mizuno M, Packer L. Effects of alpha-lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos. Biochem. Biophys Res Commun 1994; 200: 1136–1142.Google Scholar
  10. 10.
    Shibanuma M, Kuroki T, Nose K. Effects of the protein kinase C inhibitor H-7 and calmodulin antagonist W-7 on superoxide production in growing and resting human histiocytic leukemia cells (U937). Biochem Biophys Res Commun 1987; 144: 1317–1323.PubMedGoogle Scholar
  11. 11.
    Suzuki YJ, Tsuchiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 1991; 15: 255–263.PubMedGoogle Scholar
  12. 12.
    Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441–1444.PubMedCrossRefGoogle Scholar
  13. 13.
    Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone selectively induces apoptosis in human colon carcinoma cells. Cancer Res 2000; 60: 3823–3831.PubMedGoogle Scholar
  14. 14.
    Wenzel U, Kuntz S, Jambor de Sousa U, Daniel H. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int J Cancer 2003; 106: 666–675.CrossRefPubMedGoogle Scholar
  15. 15.
    Wenzel U, Kuntz S, Daniel H. NO-levels in human preneoplastic colonocytes determine their susceptibility towards anti-neoplastic agents. Mol Pharmacol 2003; 64: 1494–1502.PubMedGoogle Scholar
  16. 16.
    van de Mark K, Chen JS, Steliou K, Perrine SP, Faller DV. Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. J Cell Physiol 2003; 194: 325–340.PubMedGoogle Scholar
  17. 17.
    Sen CK, Sashwati R, Packer L. Fas mediated apoptosis of human Jurkat T-cells: Intracellular events and potentiation by redox-active alpha-lipoic acid. Cell Death Differ 1999; 6: 481–491.PubMedGoogle Scholar
  18. 18.
    Piotrowski P, Wierzbicka K, Smialek M. Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants. Folia Neuropathol 2001; 39: 147–154.PubMedGoogle Scholar
  19. 19.
    Pierce RH, Campbell JS, Stephenson AB, et al. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol 2000; 157: 221–236.PubMedGoogle Scholar
  20. 20.
    Wenzel U, Nickel A, Kuntz S, Daniel H. Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis 2004; 25: 703–712.PubMedGoogle Scholar
  21. 21.
    Deveney CW, Rand-Luby L, Rutten MJ, et al. Establishment of human colonic epithelial cells in long-term culture. J Surg Res 1996; 64: 161–169.PubMedGoogle Scholar
  22. 22.
    Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37–43.PubMedGoogle Scholar
  23. 23.
    Pou S, Huang YI, Bhan A, et al. A fluorophore-containing nitroxide as a probe to detect superoxide and hydroxyl radical generated by stimulated neutrophils. Anal Biochem 1993; 212: 85–90.PubMedGoogle Scholar
  24. 24.
    Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166: 368–379.PubMedGoogle Scholar
  25. 25.
    Wenzel U, Schoberl K, Lohner K, Daniel H. Activation of mitochondrial lactate uptake by flavone induces apoptosis in human colon cancer cells. J Cell Physiol 2005; 202: 379–390.PubMedGoogle Scholar
  26. 26.
    Serbinova E, Khwaja S, Reznick AZ, Packer L. Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart. Free Radic Res Commun 1992; 17: 49–58.PubMedGoogle Scholar
  27. 27.
    Scheer B, Zimmer G. Dihydrolipoic acid prevents hypoxic/reoxygenation and peroxidative damage in rat heart mitochondria. Arch Biochem Biophys 1993; 302: 385–390.PubMedGoogle Scholar
  28. 28.
    Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 2003; 26: 1589–1596.PubMedGoogle Scholar
  29. 29.
    Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888–895.PubMedGoogle Scholar
  30. 30.
    Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22: 359–378.PubMedGoogle Scholar
  31. 31.
    Seaton TA, Cooper JM, Schapira AH. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997; 777: 110–118.PubMedGoogle Scholar
  32. 32.
    Tsang WP, Chau SP, Kong SK, Fung KP, Kwok TT. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 2003; 73: 2047–2058.PubMedGoogle Scholar
  33. 33.
    Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J Biol Chem 2003; 278: 31998–32004.PubMedGoogle Scholar
  34. 34.
    Djavaheri-Mergny M, Wietzerbin J, Besancon F. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 2003; 22: 2558–2567.PubMedGoogle Scholar
  35. 35.
    Kurosu T, Fukuda T, Miki T, Miura O. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 2003; 22: 4459–4468.CrossRefPubMedGoogle Scholar
  36. 36.
    Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–251.PubMedGoogle Scholar
  37. 37.
    Frommel TO, Zarling EJ. Chronic inflammation and cancer: Potential role of Bcl-2 gene family members as regulators of cellular antioxidant status. Med Hypotheses 1999; 52: 27–30.PubMedGoogle Scholar
  38. 38.
    Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997; 29: 315–330.PubMedGoogle Scholar
  39. 39.
    Gatenby RA. The potential role of transformation-induced metabolic changes in tumo-host interaction. Cancer Res 1995; 55: 4151–4156.PubMedGoogle Scholar
  40. 40.
    Wang X, Levi AJ, Halestrap AP. Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells. Am J Physiol 1996; 270: 476–484.Google Scholar
  41. 41.
    Eboli ML. Pyruvate dehydrogenase levels in Morris hepatomas with different growth rate. Cancer Lett 1985; 26: 185–190.CrossRefPubMedGoogle Scholar
  42. 42.
    Board M, Newsholme E. Hydroxycitrate causes altered pyruvate metabolism by tumorigenic cells. Biochem Mol Biol Int 1996; 40: 1047–1056.PubMedGoogle Scholar
  43. 43.
    Walgren JL, Amani Z, McMillan JM, Locher M, Buse MG. Effect of R(+)alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes. Metabolism 2004; 53: 165–173.PubMedGoogle Scholar
  44. 44.
    Brand KA, Hermfisse, U. Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 1997; 11: 388–395.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Molecular Nutrition Unit, Department of Food and NutritionTechnical University of MunichFreisingFRG
  2. 2.Institute of Nutritional SciencesFreising-Weihenstephan

Personalised recommendations